Involvement of protein kinase C in reduced relaxant responses to the NO/cyclic GMP pathway in piglet pulmonary arteries contracted by the thromboxane A2-mimetic U46619

British Journal of Pharmacology

Volumn 121, Issue 7, 1997, Pages 1323-1333

  Pérez Vizcaíno, Francisco ^a   Villamor, Eduardo ^b   Duarte, Juan ^c   Tamargo, Juan ^a  

^a Instituto Nacional de Toxicologia   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

Cyclic GMP; Endothelin 1; Nitric oxide; Pulmonary artery; Thromboxane A2

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 8 BROMO CYCLIC GMP; ACETYLCHOLINE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ATRIAL NATRIURETIC FACTOR; CALCIUM ION; CYCLIC GMP; ENDOTHELIN 1; FORSKOLIN; METHYLENE BLUE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; PHORBOL 13 ACETATE 12 MYRISTATE; POTASSIUM CHANNEL; PROTEIN KINASE C; STAUROSPORINE; THAPSIGARGIN; THROMBOXANE A2;

ANIMAL TISSUE; ARTERY DILATATION; ARTERY TONE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; ENZYME ACTIVATION; MALE; MESENTERIC ARTERY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; SIGNAL TRANSDUCTION; SWINE; VASCULAR ENDOTHELIUM;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; CYCLIC GMP; ENDOTHELIN-1; MALE; NA(+)-K(+)-EXCHANGING ATPASE; NITRIC OXIDE; NITROPRUSSIDE; NOREPINEPHRINE; PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; PROTEIN KINASE C; PULMONARY ARTERY; RATS; RATS, WISTAR; SWINE; THROMBOXANE A2; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0030872153     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701257     Document Type: Article

References (56)

1. ABMAN, S.H., CHATFIELD, B., HALL, S.L. & MCMURTRY, I.F. (1990). Role of endothelium-derived releasing factor during the transition of the pulmonary circulation at birth. Am. J. Physiol., 259, H1921 H1927.
2. ABMAN, S.H. & KINSELLA, J.P. (1995). Inhaled nitric oxide for persistent pulmonary hypertension of the newborn: The physiology matters! Pediatrics, 96, 1153 1155.
3. ARCHER, S.L., HUANG, J.M.C., HAMPL, V., NELSON, D.P., SHULTZ, P.J. & WEIR, E.K. (1994). Nitric oxide and cyclic GMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cyclic GMP-dependent protein kinase. Proc. Natl. Acad. Sci. U.S.A., 91, 7583 7587.
4. BARNES, P.J. & LIU, S.F. (1995). Regulation of pulmonary vascular tone. Pharmacol. Rev., 47, 87-131.
5. CODY, R.J., HASS, G.J., BINKLEY, P.E., CAPERS, Q. & KELLEY, R. (1992). Plasma endothelin correlates with the extent of pulmonary hypertension in patients with congestive heart failure. Circulation, 85, 504 509.
6. CREMONA, G., DINH XUAN, A.T. & HIGENBOTTAM, T.W. (1991). Endothelium-derived relaxing factor and the pulmonary circulation. Lung, 169, 185-202.
7. DE NUCCI, G., THOMAS, R., D'ORLEANS-JUSTE, P., ANTUNES, E., WALDER, C., WARNER, T. & VANE, J.R. (1988). Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. U.S.A., 85, 9797-9800.
8. DINH-XUAN, A.T., HIGENBOTTAM, W., CLELLAND, T.W., PEPKEZABA, J., CREMONA, G., BUTT, A. Y., LARGE, S.R., WELES, F.C. & WALLWORK, J. (1991). Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N. Engl. J. Med., 324, 1539 1547.
9. DOBYNS, E.L., WESCOTT, J.Y., KENNAUGH, J.M., ROS, M.N. & STENMARK, K.R. (1994). Eicosanoids decrease with successful extracorporeal membrane oxygenation therapy in neonatal pulmonary hypertension. Am. J. Respir. Crit. Care Med., 149, 873-880.
10. FALKE, K.J. (1993). Long term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med., 19, 443-449.
11. FERRER, M., ENCABO, A., CONDE, M.V., MARIN, J. & BALFAGON, G. (1995). Heterogeneity of endothelium-dependent mechanisms in different rabbit arteries. J. Vasc. Res., 32, 339-346.
12. FROSTELL, C., FRATACCI, M.D., WAIN, J.C., JONES, R. & ZAPOL, W.M. (1991). Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation, 83, 2038-2047.
13. GARCIA-SZABO, R.R., JOHNSON, A. & MALIK, A.B (1988). Thromboxane increases pulmonary vascular resistance and transvascular fluid and protein exchange after pulmonary microembolism. Prostaglandins, 35, 707-721.
14. GIAID, A. & SALEH, D (1995). Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N. Engl. J. Med., 333, 214-221.
15. GIAID, A., YANAGISAWA, M., LANGLEBEN, D., MICHEL, R.P., LEVY, R., SHENNIB, H., KIMURA, S., MASAKI, T., DUGUID, W.P. & STEWART, D.J. (1993). Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N. Engl. J. Med., 328, 1732 1739.
16. GIBSON, R.L., TRUOG, W.E. & REDDING, G.J. (1987). Thromboxane-associated pulmonary hypertension during three types of Gram-positive bacteriemia in piglets. Pediatr. Res., 23, 553-556.
17. HIDAKA, H. & KOBAYASHI, R. (1992). Pharmacology of protein kinase inhibitors. Annu. Rev. Pharmacol. Toxicol., 32, 377-397.
18. HIRATA, M., KOHSE, K.P., CHANG, C.-H., IKEBE, T. & MURAD, R. (1990). Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. J. Biol. Chem., 265, 1268-1273.
19. IGNARRO, L.J., BYRNS, R.E. & WOOD, K.S. (1987). Endothelium-dependent modulation of cyclic GMP levels and intrinsic smooth muscle tone in isolated bovine intrapulmonary artery and vein. Circ. Res., 60, 89 92.
20. IGNARRO, L.J., HARBISON, R.G., WOOD, K.S. & KADOWITZ, P.J. (1986). Dissimilarities between methylene blue and cyanide on relaxation and cyclic GMP formation in endothelium-intact intrapulmonary artery caused by nitrogen oxide-containing vasodilators and acetylcholine. J. Pharmacol. Exp. Ther., 236, 30-36.
21. KINSELLA, J.P., NEISH, S.R., IVY, D.D., SCHAFFER, E. & ABMAN, S.H. (1993). Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J. Pediatr., 123, 103-108.
22. KLEMM, P., THIEMMERMAN, C., WINKLMAIER, G., MARTORANA, P.A. & HENNING, R. (1995). Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxic shock. Br. J. Pharmacol., 114, 363-368.
23. KOWALUK, E.A., SETH, P. & FUNG, H.-L. (1992). Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J. Pharmacol. Exp. Ther., 262, 916 922.
24. LEVY, M., TULLOH, R.M., KOMAI, H., STUART-SMITH, K. & HAWORTH, S.G. (1995). Maturation of the contractile response and its endothelial modulation in newborn porcine intrapulmonary arteries. Pedriatr. Res., 38, 25-29.
25. 2+ by cAMP in vascular smooth muscle cells. Am. J. Physiol., 258, C399 C407.
26. LINCOLN, T.M., KOMALAVILAS, P. & CORNWELL, T.L. (1994). Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase, Hypertension, 23, 1141 1147.
27. ++-pump ATPase inhibit relaxation by nitroglycerin and atrial natriuretic factor of the rabbit aorta contracted by phenylephrine. J. Pharmacol. Exp. Ther., 265, 1187 1192.
28. MCQUESTON, J.A., KINSELLA, J.P., IVY, D.D., MCMURTRY, I.F. & ABMAN, S.H. (1995). Chronic pulmonary hypertension in utero impairs endothelium-dependent vasodilation. Am. J. Physiol., 268, H288 H294.
29. + channels and depolarizes smooth muscle cells of porcine coronary artery. Circ. Res., 70, 612 616.
30. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev.,43, 109-142.
31. MONTALESCOT, G., LOWENSTEIN, E., OGLETREE, M.L., GREENE, E.M., ROBINSON, D.R., HARTL, K. & ZAPOL, W.M. (1990). Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep. Circulation, 82, 1765 1777.
32. MORRISON, K.J. & POLLOCK, D. (1990). Impairment of relaxations to acetylcholine and nitric oxide by a phorbol ester in rat isolated aorta. Br. J. Pharmacol., 101, 432-436.
33. NEONATAL INHALED NITRIC OXIDE STUDY GROUP. (1997). Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. New Engl. J. Med., 336, 597-604.
34. 4 in unanesthetized sheep: Role of thromboxane. J. Appl. Physiol., 60, 765-769.
35. OHGUSHI, M., YASUE, H., KUGIYAMA, K., MUROHARA, T. & SAKAINO, N. (1993). Contraction and endothelium-dependent relaxation via alpha adrenoceptors are variable in various pig arteries. Cardiovasc. Res., 27, 779-784.
36. PEPKE-ZABA, J., HIGENBOTTAM, T.W., DINH-XUAN, A.T., RIDDEN, C. & KEALEY, T. (1993). Alpha-adrenoceptor stimulation of porcine pulmonary arteries. Eur. J. Pharmacol., 235, 169-175.
37. PEREZ-VIZCAINO, F., VILLAMOR, E., FERNANDEZ DEL POZO, B., MORO, M. & TAMARGO, J. (1996). Lack of endotoxin-induced hyporesponsiveness to U46619 in isolated neonatal porcine pulmonary but not mesenteric arteries. J. Vasc. Res., 33, 249-257.
38. PUSSARD, G., GASCARD, J.-P., GORENNE, I., LABAT, C., NOREL, X., DULMET, E. & BRINK, C. (1995). Endothelin-1 modulates cyclic GMP production and relaxation in human pulmonary vessels. J. Pharmacol. Exp. Ther., 274, 969-975.
39. RAPOPORT, R.M., SCHWARTZ, K. & MURAD, F. (1985). Effect of sodium-potassium pump inhibitors and membrane-depolarizing agents on sodium nitroprusside-induced relaxation and cyclic guanosine monophosphate accumulation in rat aorta. Circ. Res., 57, 164-170.
40. 2+-ATPase by cyclic GMP-dependent protein kinase. Proc. Natl. Acad. Sci. U.S.A., 84, 5685-5689.
41. ROBERTS, J.D., FINEMAN, J.R., MORIN III, F.C., SHAUL, P.W., RIMAR, S., SCHREIBER, M.D., POLIN, R.A., ZWASS, M.S., ZAYEC, M.M., GROSS, I., HEYMANN, M.A. & ZAPOL, W.M. (1997). Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. New Engl. J. Med., 336, 605-610.
42. ROSENBERG, A.A., KENNAUGH, J., KOPPENHAFER, S.L., LOOMIS, M. & ABMAN, S.H. (1993). Elevated immunoreactive endothelin-1 levels in infants with persistent pulmonary hypertension of the newborn. J. Pediatr., 123, 109-114.
43. Ca channel activity from pig coronary artery. Am. J. Physiol., 262, C708-C713.
44. SEAMON, K.B. & DALY, J.W. (1986). Forskolin: Its biological and chemical properties. Adv. Cyclic Nucleotide Res., 20, 1-150.
45. STRADER, C.D., FONG, T.M., GRAZIANO, M.P. & TOTA, M.R. (1995). The family of G-protein-coupled receptors. FASEB J., 9, 745-754.
46. 2+ ATPase. Proc. Natl. Acad. Sci. U.S.A., 87, 2466-2470.
47. VILLAMOR, E., PEREZ-VIZCAINO, F., RUIZ, T., TAMARGO, J. & MORO, M. (1996a). In vitro effects of magnesium sulfate in isolated intrapulmonary and mesenteric arteries of piglets. Pediatr. Res., 39, 1107-1112.
48. VILLAMOR, E., PEREZ-VIZCAINO, F., TAMARGO, J. & MORO, M. (1996b). Effects of group B Streptococcus on the responses to U46619, endothelin-1 and noradrenaline in isolated pulmonary and mesenteric arteries of piglets. Pediatr. Res., 40, 827-833.
49. WARNER, T.D., MITCHELL, J.A., SHENG, H. & MURAD, F. (1994). Effects of cyclic GMP on smooth muscle relaxation. Adv. Pharmacol., 26, 171-194.
50. WEITZBERG, E., HEMSEN, A., RUDEHILL, A., MODIN, A., WANECEK, M. & LUNDBERG, J.M. (1996). Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock. Br. J. Pharmacol., 118, 617-626.
51. WEITZBERG, E., LUNDBERG, J.M. & RUDEHILL, A (1995). Inhibitory effects of diclofenac on the endotoxin shock response in relation to endothelin turnover in the pig. Acta Anaesthesiol. Scand., 39, 50-59.
52. WEITZBERG, E., RUDEHILL, A. & LUNDBERG, J.M. (1993). Nitric oxide inhalation attenuates pulmonary hypertension and improves gas exchange in endotoxin shock. Eur. J. Pharmacol., 233, 85-94.
53. WELTE, M., ZWISSLER, B., HABLER, O., KLEEN, M. & MESSMER, K. (1995). Prostacyclin aerosol and inhaled nitric oxide fail to reverse pulmonary vasoconstriction induced by thromboxane analogue in dogs. Acta Physiol. Scand., 154, 395-405.
54. YOSHIBAYASHI, M., NISHIOKA, K., NAKAO, K., SITO, Y., MATSUMURA, M., UEDA, T., TEMA, S., SHIRAKAMI, G., IMURA, H. & MIKAWA, H. (1991). Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart disease. Circulation, 84, 2280-2285.
55. ZAMORA, C.A., BARON, D.A. & HEFFNER, J.E. (1993). Thromboxane contributes to pulmonary hypertension in ischaemia-reperfusion lung injury. J. Appl. Physiol., 74, 224-229.
56. ZIEGLER, J.P., IVI, D.D., FOX, J.J., KINSELLA, J.P., CLARKE, W.R. & ABMAN, S.H. (1995). Dipirydamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus. Am. J. Physiol., 269, H473-479.